Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-514P (RNA, U6 small nuclear 514, pseudogene) is a **pseudogene** and not a protein-coding gene or functional RNA. It belongs to a class of genomic sequences that resemble functional genes but are generally considered nonfunctional due to accumulated mutations or lack of proper transcriptional regulation[2][6]. RNU6-514P is derived from the genuine U6 small nuclear RNA (snRNA) gene, which itself is a component of the spliceosome and essential in pre-mRNA splicing[1][3]. However, as a pseudogene, RNU6-514P does not produce functional U6 snRNA and has no known biological activity or role as a therapeutic or diagnostic target[6]. There are many such U6 snRNA pseudogenes in the genome, arising through evolutionary duplication events; while they retain high sequence similarity, they lack functional roles[4][5]. There is no evidence for involvement of RNU6-514P in disease, drug interactions, or use as a biomarker. This entry should not be considered a likely drug target or relevant in therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 514, pseudogene (RNU6-514P).